Figure 6.
TEMPAI is not modulated by TGF-β in MM cells. A, MM cell line RPMI-8226 and lung cancer cell line H1299 were treated with TGF-β for 5 or 12 h, followed by cell lysates preparation and Western blotting assay. B, MM cell lines (RPMI-8226 and LP1) and solid tumor cell lines (breast cancer cell line MCF7, prostate cancer cell line PC3, and cervical cancer cell line HeLa) were treated with increased TGF-β for 12 h, followed by immunoblotting assay against TMEPAI.